Welcome to Hepatitis Central!
All the information you need about living with Hepatitis C, including the latest news about infection, transmission, symptoms, treatment breakthroughs and medical progress.
Some of our most commonly asked questions and our answers to them.
Learn about the Hepatitis C Virus (HCV).
Information about the transmission of Hepatitis C.
You'll find links to a comprehensive symptoms list, as well as various studies and discussions about Hepatitis C symptoms.
Learn about the conventional medical treatments used to fight Hepatitis C.
Numerous links to studies, info sheets, FAQs, and analysis of Ribavirin/Rebetron medicines.
Alternative methods of treatment due to side effects and dissatisfication with current medical treatments.
A number of herbal products useful in the management of liver disease.
Receive the latest news on hepatitis treatments, clinical trials, social issues and important breakthroughs.
Learn about Hepatitis C Genotypes and their variants.
A state-by-state and worldwide reference listing physicians who treat HCV, including an email link to submit your physician for inclusion.
Convenient links to other sites external to Hepatitis-Central.
A Bulletin Board for discussions on hepatitis, treatments, etc.
An easy way to get involved in urging our government to do more for Hepatitis C awareness and treatment research.
Numerous links to various Hepatitis B related information, including transmission, symptoms and treatment.
A comprehensive resource of information relating to the liver biopsy.
Many discussions and analyses of cirrhosis, including causes, complications, pathology, symptoms, and much more.
Commonly used medical terms and definitions.
What they are and what they mean. Helps you interpret & understand all the various hepatitis lab tests likely to be encountered.
Liver Cancer/Hepatocellular Carcinoma studies, info sheets, FAQs, and analysis.
An exhaustive list of links to studies, info sheets, FAQs, and analysis of the various drugs used to treat liver disease.
Provides information regarding the best known liver supporting supplements.
Provides detailed information on how to analyze and interpret viral load numbers as well as a link to a convenient Viral Load Chart.
Learn more about various Hepatitis C related topics, including HCV, Ascites, Biopsies, and much more.
Recommended reading for those interested in hepatitis information.
Hepatitis C News and Updates
Hepatitis Central News & Original Articles
Find out about Sovaldi (sofosbuvir), the second drug the FDA has approved since the end of November for the treatment of Hepatitis C. Read more.
Find out about AbbVie Inc. and its progress in developing an oral treatment for Hepatitis C. Read more.
Learn more about samatasvir, simeprevir and TMC647055 – all of which are being tested for an all-oral, direct-acting antiviral (DAA) HCV combination therapy. Read more.
By way of protein analysis, scientists at The Scripps Research Institute (TSRI) are forging ahead in the race to create a Hepatitis C vaccine. Read more.
Janssen Therapeutics' OLYSIO™ (simeprevir) has been approved by the FDA. It is a prescription medicine used with other antiviral medicines to treat genotype 1 chronic hepatitis C in adults. Learn more about how OLYSIO™ works. Read more.
When should you tell your date you have Hepatitis C… and what do you say? Read more.
Help make sure your Thanksgiving feast fortifies your liver and squelches any active Hepatitis C virions. Discover which four sides to eat and which four to pass on. Read more.
A Phase 2b trial of ABT-450 (a once-a-day, all-oral drug regimen) revealed an average sustained virologic response of 95 percent in newly-diagnosed patients. Read more.
- FDA Approves 2nd Drug for Treatment of Chronic HCV
- AbbVie Tries to Develop Hep C Regimen Without Interferon
- Patient Enrollment Started in the Phase II HELIX-2 Clinical Trial
- Exciting Development in Search for Hepatitis C Vaccine
- Breaking News: FDA Approves New Treatment for Hep C (Genotype 1)
- Telling Your Date You Have Hepatitis C
- Hep C Lifestyle Guide: Good and Bad Thanksgiving Meal Sides
- ABT-450 Shows Promising Results for Hepatitis C Patients
Hepatitis C Poll
Which Hep-C friendly side dish are you looking forward to trying this year at Thanksgiving?
- Baked Sweet Potatoes - 39%
- Shaved Brussels Sprouts with Lemon - 8%
- Beet and Apple Salad - 7%
- Quinoa Stuffing with Walnuts, Cranberry and Artichoke - 5%
- None of the Above - 10%
- All of the Above! - 30%
Most Searched Articles in our Hepatitis C Archive
- Is Coffee a Wise Adjunct to Hepatitis C Therapy?
- Hepatitis C Report: Four Food Groups to Lift Depression
- Interferon-Free Combo Squashes the Hepatitis C Virus
- Do Home Remedies for Hepatitis C Work?
- Surprising Data on What Typically Ends the Fight Against Hep C
- New Hepatitis C Drug Has Steep Price Tag
- Two Liver Cancer Discoveries May Impact Hepatitis Patients
- Fast-Track Given to Hepatitis C Drug ACH-1625
Living With Hepatitis C
When you or someone you love is Living with Hepatitis C, you need as much reliable information as you can find. Hepatitis-Central.com is here to help educate patients and their families about hepatitis, its symptoms and all the available treatment options. With our editors continuously scanning press releases, news reports and clinical trial results, this is where you'll first learn about breakthrough treatments and critical information on related conditions such as ascites, elevated liver enzymes and autoimmune hepatitis.
Keep Up-To-Date With New Hepatitis C Info As It Is Announced
A wide range of new information is being published regularly. As a patient, you need the most up-to-date information available. Sign up today for Hepatitis-Central's email newsletter, Research and Treatment News.
Hepatitis C Is a Deadly Disease
According to Dr. Eugene Schiff (University of Miami), the Hepatitis C virus (HCV) emerged in the U.S. population beginning in the 1960s, related to blood transfusion and injection drug use. The extent of the problem was only apparent after 1990 when reliable HCV blood tests first became available. Studies indicate that over the first 20 years of chronic Hepatitis C infection, 20% of chronically infected patients will develop cirrhosis, and many of those will progress to liver cancer. HCV-associated end-stage liver disease is a leading indication for liver transplantation in the USA and the developed western world.
Millions of Patients Are Affected by Hepatitis C
Currently, it is estimated there are about 130 -170 million people worldwide who are infected with Hepatitis C, of which approximately 4 million are in the United States. Hepatitis C accounts for 8,000-10,000 deaths each year in the United States.
The CDC (Centers For Disease Control) estimates that there may be up to 17,000 new Hepatitis C infections in the U.S. every year. Worldwide it is estimated there are 3-4 million people infected with HCV each year. Countries with the highest infection rates are Egypt (22%), Pakistan (4.8%) and China (3.2%). 80% of those infected with the Hepatitis C virus will not have any initial symptoms and therefore new infections are rarely identified.
Of those infected with HCV approximately 75-85% will eventually develop chronic Hepatitis C infections. Once chronically infected approximately 60-70% will develop chronic liver disease, between 5-20% will develop cirrhosis over a period of 20-30 years, and 1-5% die from cirrhosis or liver cancer.
The incidence of new symptomatic infections of HCV has been estimated to be 13 cases/100,000 persons annually. For every one person that is infected with the AIDS virus, there are more than four infected with HCV.
The Public Effects Are Going to Get Worse, Fast
Over the next 10-20 years chronic Hepatitis C is predicted to become a major burden on the health care system as patients who are currently asymptomatic with relatively mild disease progress to end-stage liver disease and develop hepatocellular carcinoma. Predictions in the USA indicate that there will be a 60% increase in the incidence of cirrhosis, a 68% increase in hepatoma incidence, a 279% increment in incidence of hepatic decompensation, a 528% increase in the need for transplantation, and a 223% increase in liver death rate.
Current Medical HCV Treatment Is Limited
Current medical treatment for Hepatitis C is limited. Pegylated interferon/ribavirin combination therapy is effective in less than 50% of cases of HCV genotype 1 (the most common genotype in North America). Two companies, Roche and Schering, have their own FDA approved versions. Each claims their formulation is superior for treating Hepatitis C.
May 2011 two new drugs were approved by the U.S. Food and Drug Administration for use with pegylated interferon and ribavirin - Victrelis™ (boceprevir) and Incivek™ (telaprevir). In clinical studies they were shown to decrease treatment time and increase sustained virologic response (SVR) in patients that have not been treated before or who have failed previous Hepatitis C treatment.
Some Natural Therapies Have Real Value
There are also natural approaches for dealing with Hepatitis C. The credible ones focus on protecting and supporting the liver and keeping the immune system healthy. There is some proof that you can use natural means to help you live a long and relatively healthy life with this virus and die of some other cause (preferably old age). There is no natural cure for Hepatitis C, and if anyone claims they have one, they are lying. It is as simple as that.
Dubious treatments and supposed cures for HCV are being sold by charlatans and rip off artists. You need to be discerning when considering alternative therapies to help you deal with HCV. Look for scientific clinical validation. Objective third-party proof of effectiveness and safety is essential. We are involved with one product we think very highly of called UltraThistle. It is a high quality medical milk thistle with scientific validation and a very reasonable price.